Prof. Dr. Joost Verhoeff Inaugural Symposium: "The Future of MR in Radiotherapy:Towards Patient-centric Biomarkers".
Invited presentation delivered by Dr. Fuller on 2025-03-14T1115 at De Veranda, Amstelveenseweg 764, 1081 JK Amsterdam, NL, as part of the Symposium for the Inauguration of Prof. Dr. Joost Verhooef, entitled "De Menselijke Maat", upon his appointment to the Professorship of Vrije Universiteit Amsterdam (Free University Amsterdam).
Precis:
The development of advanced radiotherapy delivery enables a move towards quantitative imaging not only for tumor/non-tumor discrimination/segmentation, but as a move towards functional physiologic imaging using quantitative methods for patient-specific therapy and toxicity monitoring. MRI represents a readily-implemented platform for multi-parametric representation for radiotherapy applications, and the proposed talk discusses the current and future opportunities and challenges using head and neck cancer treatment and toxicity as a use-case.
Funding
SMART-ACT: Spatial Methodologic Approaches for Risk Assessment and Therapeutic Adaptation in Cancer Treatment
National Cancer Institute
Find out more...QuBBD: Precision E –Radiomics for Dynamic Big Head & Neck Cancer Data
National Cancer Institute
Find out more...Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-Enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)
National Institute of Dental and Craniofacial Research
Find out more...R01DE028290- Development of functional magnetic resonance imaging-guided adaptive radiotherapy for head and neck cancer patients using novel MR-Linac device
R01DE025248- Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular Osteoradionecrosis
Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular Osteoradionecrosis
National Institute of Dental and Craniofacial Research
Find out more...